What is the appropriate ondansetron injection dose for a child weighing 15.6 kg?

Ondansetron Dosing for a 15.6 kg Child

For a child weighing 15.6 kg, administer ondansetron 0.1 mg/kg intravenously (1.56 mg, or approximately 0.8 mL of the 2 mg/mL injection) for prevention of postoperative nausea and vomiting, given as a single dose over at least 30 seconds. 1

Context-Specific Dosing

The appropriate ondansetron dose depends critically on the clinical indication:

For Postoperative Nausea and Vomiting (PONV)

• Dose: 0.1 mg/kg IV (maximum 4 mg per dose)
• Administration: Single dose over at least 30 seconds
• No dilution required before administration 1
• For this 15.6 kg child: 1.56 mg (0.78 mL of 2 mg/mL solution)

For Chemotherapy-Induced Nausea and Vomiting (CINV)

• Dose: 0.15 mg/kg IV (maximum 16 mg per dose)
• Administration: Infuse over 15 minutes, given 30 minutes before chemotherapy, then repeat at 4 and 8 hours after first dose (3 total doses)
• Dilution required: Must dilute in 10-50 mL of 5% dextrose or 0.9% sodium chloride for pediatric patients ≤10 kg or between 6 months-1 year 1
• For this 15.6 kg child: 2.34 mg per dose (1.17 mL of 2 mg/mL solution)

Key Clinical Distinctions

The PONV dose (0.1 mg/kg) is lower than the CINV dose (0.15 mg/kg) because the emetogenic stimulus differs substantially. Research demonstrates that even lower doses (0.05 mg/kg) can be effective for PONV 2, though the FDA-approved dose remains 0.1 mg/kg 1.

Important Preparation Differences

• PONV: Give undiluted, push over ≥30 seconds
• CINV: Must dilute and infuse over 15 minutes 1

This distinction matters because improper administration can affect efficacy and safety.

Evidence Quality Considerations

The FDA labeling 1 provides the definitive dosing guidance, derived from multiple pediatric trials. Research supports that:

• Doses as low as 0.05 mg/kg show efficacy for PONV 2, 3
• The 0.15 mg/kg dose for CINV can be given every 4-6 hours 4
• Divided dosing (0.15 mg/kg every 8 hours) may reduce nausea better than single daily dosing in children <7 years 5

Common Pitfalls to Avoid

1. Don't confuse PONV and CINV dosing - they differ by 50% (0.1 vs 0.15 mg/kg)
2. Don't dilute for PONV - only CINV requires dilution 1
3. Don't exceed maximum single doses - 4 mg for PONV, 16 mg for CINV
4. Don't give repeat PONV doses routinely - a second 4 mg dose postoperatively provides no additional benefit in adults who received prophylaxis 1

Safety Profile

Ondansetron is well-tolerated in this age group. Monitor for:

• QT prolongation (rare, primarily with IV administration) 1
• Constipation (11% in chemotherapy patients) 1
• Transient transaminase elevations (approximately 5%) 1

No dose adjustment is needed for renal impairment in children 1. The pharmacokinetics in pediatric patients show higher clearance than adults, supporting weight-based dosing 1.